Griffithsin's Safety and Efficacy as a Microbicide Candidate
Author Information
Author(s): Kouokam Joseph Calvin, Huskens Dana, Schols Dominique, Johannemann Andrew, Riedell Shonna K., Walter Wendye, Walker Janice M., Matoba Nobuyuki, O'Keefe Barry R., Palmer Kenneth E.
Primary Institution: University of Louisville School of Medicine
Hypothesis
Does Griffithsin have a safe and effective profile as a microbicide candidate against HIV?
Conclusion
Griffithsin has an outstanding safety profile with minimal toxicity and retains antiviral activity against HIV.
Supporting Evidence
- GRFT binds to human epithelial and PBMC cells through oligosaccharide-dependent interactions.
- GRFT treatment induces minimal changes in inflammatory cytokine secretion.
- GRFT does not significantly upregulate markers of T-cell activation.
Takeaway
Griffithsin is a natural protein that can help prevent HIV without causing harm to human cells.
Methodology
The study involved binding assays, cell viability tests, and gene expression analysis using human cervico-vaginal cell lines and PBMC.
Potential Biases
Potential conflicts of interest due to funding sources and author affiliations.
Limitations
The study primarily focused on in vitro models, which may not fully represent in vivo conditions.
Participant Demographics
Freshly isolated PBMC from 3 different donors were used.
Statistical Information
P-Value
0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website